Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathan Mehta

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
International Journal of Cardiology|June 21, 2014
Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trialsNaga Venkata K Pothineni, Abhishek Deshmukh, Sadip Pant, et al.
Clinical Lung Cancer|February 25, 2023
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung CancerWade T Iams, Meridith L Balbach, Sharon Phillips, et al.
International Journal of Cardiology|August 10, 2013
Presence of anti-viral and anti-parasitic antibodies and cardiovascular mortality: insights from NHANES IIIPeeyush M Grover, Apurva O Badheka, Neeraj Shah, et al.
The American Journal of Cardiology|September 11, 2014
Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010])Sidakpal S Panaich, Apurva O Badheka, Ankit Chothani, et al.
Circulation|May 21, 2014
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planningNileshkumar J Patel, Abhishek Deshmukh, Sadip Pant, et al.
Circulation|September 25, 2013
In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 proceduresAbhishek Deshmukh, Nileshkumar J Patel, Sadip Pant, et al.
International Journal of Cardiology|August 20, 2013
Non-influence of lipid lowering therapy in atrial fibrillation recurrenceKathan Mehta, Peeyush M Grover, Neeraj Shah, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 24, 2014
Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspectiveVikas Singh, Apurva O Badheka, Nileshkumar J Patel, et al.
International Journal of Cardiology|December 31, 2013
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic functionNileshkumar J Patel, Michael Hoosien, Abhishek Deshmukh, et al.
The American Journal of Cardiology|February 11, 2014
Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategyApurva O Badheka, Neeraj Shah, Peeyush M Grover, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
International Journal of Cardiology|June 21, 2014
Complication rates of atrial fibrillation ablations: comparison of safety outcomes from real world to contemporary randomized control trialsNaga Venkata K Pothineni, Abhishek Deshmukh, Sadip Pant, et al.
Clinical Lung Cancer|February 25, 2023
A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung CancerWade T Iams, Meridith L Balbach, Sharon Phillips, et al.
International Journal of Cardiology|August 10, 2013
Presence of anti-viral and anti-parasitic antibodies and cardiovascular mortality: insights from NHANES IIIPeeyush M Grover, Apurva O Badheka, Neeraj Shah, et al.
The American Journal of Cardiology|September 11, 2014
Results of ventricular septal myectomy and hypertrophic cardiomyopathy (from Nationwide Inpatient Sample [1998-2010])Sidakpal S Panaich, Apurva O Badheka, Ankit Chothani, et al.
Circulation|May 21, 2014
Contemporary trends of hospitalization for atrial fibrillation in the United States, 2000 through 2010: implications for healthcare planningNileshkumar J Patel, Abhishek Deshmukh, Sadip Pant, et al.
Circulation|September 25, 2013
In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 proceduresAbhishek Deshmukh, Nileshkumar J Patel, Sadip Pant, et al.
International Journal of Cardiology|August 20, 2013
Non-influence of lipid lowering therapy in atrial fibrillation recurrenceKathan Mehta, Peeyush M Grover, Neeraj Shah, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 24, 2014
Influence of hospital volume on outcomes of percutaneous atrial septal defect and patent foramen ovale closure: a 10-years US perspectiveVikas Singh, Apurva O Badheka, Nileshkumar J Patel, et al.
International Journal of Cardiology|December 31, 2013
Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic functionNileshkumar J Patel, Michael Hoosien, Abhishek Deshmukh, et al.
The American Journal of Cardiology|February 11, 2014
Outcomes in atrial fibrillation patients with and without left ventricular hypertrophy when treated with a lenient rate-control or rhythm-control strategyApurva O Badheka, Neeraj Shah, Peeyush M Grover, et al.
Pageof 5